Background: AMP-activated protein kinase (AMPK) not only functions as an intracellular energy sensor and regulator, but is also a general sensor of oxidative stress. Furthermore, there is recent evidence that it participates in limiting acute inflammatory reactions, apoptosis and cellular senescence. Thus, it may oppose the development of chronic obstructive pulmonary disease. Methods: To investigate the role of AMPK in cigarette smoke-induced lung inflammation and emphysema we first compared cigarette smoking and polyinosinic-polycytidylic acid [poly(I:C)]-induced lung inflammation and emphysema in AMPKa1-deficient (AMPKa1-HT) mice and wild-type mice of the same genetic background. We then investigated the role of AMPK in the induction of interleukin-8 (IL-8) by cigarette smoke extract (CSE) in A549 cells. Results: Cigarette smoking and poly(I:C)-induced lung inflammation and emphysema were elevated in AMPKa1-HT compared to wild-type mice. CSE increased AMPK activation in a CSE concentration-and time-dependent manner. 5-Aminoimidazole-4-carboxamide-1-b-4-ribofuranoside (AICAR), an AMPK activator, decreased CSE-induced IL-8 production while Compound C, an AMPK inhibitor, increased it, as did pretreatment with an AMPKa1-specific small interfering RNA. Conclusion: AMPKa1-deficient mice have increased susceptibility to lung inflammation and emphysema when exposed to cigarette smoke, and AMPK appears to reduce lung inflammation and emphysema by lowering IL-8 production.
Introduction
Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation that is associated with an enhanced chronic inflammatory response in the airways and lungs to noxious particles or gases 1 . Cigarette smoking is the most important risk factor for the development of COPD. Chronic smoke exposure causes airway and lung parenchymal inflammation which leads to small airway disease (obstructive bronchiolitis) and emphysema. The biologic nature of COPD inflammation is not well understood, and pharmacological agents that inhibit inflammation in COPD are urgently needed. The so-called traditional hypothesis states that COPD is initiated and maintained by the activation of inflammation by long-term cigarette smoking, leading to a protease/anti-protease imbalance 2 . Though this hypothesis has compelling experimental and observational clinical support, it does not address several observations particularly related to the progressive nature of COPD: the several decades of smoking required to develop the disease 3 , the persistence of inflammation despite smoking cessation 4 , and the vexing observation that corticosteroids have little impact in COPD 5 . Additional hypotheses for the pathogenic mechanism of COPD include oxidative stress, auto-immunity, apoptosis and senescence [6] [7] [8] [9] [10] [11] . More research on the cellular and molecular mechanisms that regulate the development and progression of COPD is required to identify novel therapeutic targets .
AMP-activated protein kinase (AMPK) is a well-known energy sensor that is activated by increased intracellular AMP levels 12 . AMPK activation is initiated by alterations in cellular metabolic state that result from inhibition of ATP generation, such as hypoxia, glucose deprivation, heat shock, or reduction in mitochondrial oxidative phosphorylation, or from increased ATP consumption, such as occurs during exercise or when cellular metabolism increases. AMPK not only functions as an intracellular energy sensor and regulator, but is also a general stress sensor that is important in maintaining intracellular homoeostasis during oxidative stress and other potentially damaging situations 13, 14 . Furthermore, there is also evidence that it reduces acute inflammatory reactions, apoptosis, and cellular senescence [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] . Based on these findings, we reasoned that AMPK might be involved in limiting COPD pathogenesis. In the present study, we sought to investigate its possible role in modulating cigarette smoking-induced lung inflammation and emphysema. To examine these issues, we first compared cigarette smoke-and polyinosinic-polycytidylic acid [poly(I:C)]-induced lung inflammation and emphysema in AMPKa1-deficient (AMPKa1-HT) mice and wild type mice of the same genetic background. We subsequently investigated the role of AMPK in the induction of interleukin (IL)-8 by cigarette smoke extract (CSE) in A549 cells.
Materials and Methods

Reagents and antibodies
We purchased poly(I:C) from InvivoGen (San Diego, CA, USA). 5-Aminoimidazole-4-carboxamide-1-b-4-ribofuranoside (AICAR), an activator of AMPK and Compound C, an inhibitor of AMPK, were purchased from Merck Millipore (Darmstadt, Germany). For immunoblot analysis, antibodies against b-actin, AMPK-a, phospho-AMPK-a, and microtubuleassociated protein 1 light chain 3-I/II were purchased from Cell Signaling Technology (Danvers, MA, USA). Anti-IL-8 and tumor necrosis factor a (TNF-a), antibody were from Santa Cruz Biotechnology (Dallas, TX, USA).
Mice
Heterozygous AMPKa1-deficient (AMPKa1-HT) C57BL/6 mice were generously provided by Professor Benoit Violet (INSERM U567, Paris, France) and bred in specific pathogenfree conditions in the facility of the Asan Institute for Life Science. Animal experiments were approved by the Institutional Animal Care and Use Committee of Asan Medical Center, Seoul, Korea. Mice were exposed to the mainstream smoke of 20 filtered commercial cigarettes per day, each containing 8.0 mg tar and 0.8 mg nicotine (This Wild; KT&G, Daejeon, Korea). The mice were exposed to cigarette smoke 5 days per week for 2 months. Ten to twelve mice were settled in an inhalation box (50×40×30 cm) connected to a pump and were exposed for 10 minutes to mainstream cigarette smoke generated simultaneously from 10 cigarettes. The mice remained in the box for an additional 10 minutes after the cigarettes had burned out. The box was then ventilated to remove the cigarette smoke, and the mice breathed normal room air for 5 minutes. A second Tuberc Respir Dis 2015;78:8-17
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www.e-trd.org exposure was performed in the same manner. Thereafter the mice were returned to their cages. Control animals inhaled clean room air only in the cages. After 2 weeks of cigarette smoke exposure, 50 mL poly(I:C) or their vehicle controls were administered twice per week (every Monday and Thursday) for 2 weeks (days 15, 18, 22, and 25, respectively) via nasal aspiration. Cigarette smoke exposure was continued during this period.
Preparation of bronchoalveolar lavage fluid cells and lung tissues
At the end of each experiment, mice were anesthetized with isoflurane and a middle thoracotomy was performed. The trachea was cannulated and perfused with three 0.7-mL aliquots of cold saline. The heart and lungs were then removed en bloc. The left main bronchus was ligated, and the right lung was inflated by intratracheal infusion of 0.3% low-melting agar at 25 cm H 2 O. This allowed for homogenous expansion of the lung parenchyma, as described previously 27 . The inflated right lung was fixed with 4% paraformaldehyde and embedded in paraffin, and the left lung was stored at - 
AMPK activity in lung tissue
AMPK activation was assessed as the ratio of phospho-AMPK to total AMPK after correction for local background intensity and normalization to b-actin. Lung tissue was homogenized in lysis buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1mM b-glycerophosphate, 50 mM NaF, 1 mM Na 3 VO 4 , 1 mg/mL of leupeptin, 10 mg/mL aprotinin, and 1 mM AEBSF). Lung tissue proteins were analyzed by 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting with mouse monoclonal anti-total AMPK-a antibodies (Cell Signaling Technology) and rabbit monoclonal anti-phospho-AMPK-a at thr172 (Cell Signaling Technology).
Lung morphometry
Lung sections of 4-mm thickness were used for histological analysis. Mean linear intercepts (MLI) were determined on paraffin-embedded lungs by staining with hematoxylin and eosin, as described previously 28 . All histological examinations were made by two investigators in a blinded manner.
Cell culture
Alveolar type II-like epithelial cell line A549 (#CCL-185; American Type Culture Collection, Manassas, VA, USA) was maintained in Dulbecco' s modified Eagle' s medium containing 10% fetal calf serum. A549 cells were cultured for 24 hours in 100-mm tissue culture plates in RPMI 1640 (American Type Culture Collection) supplemented with 10% fetal bovine serum (Invitrogen, Carlsbad, CA, USA), 100 U/mL penicillin, and 100 mg/mL streptomycin (Life Technologies Inc., Frederick, MD, USA). The cells were incubated at 37 o C in a humidified atmosphere containing 5% CO 2 and 95% air and pretreated with AICAR (1 mM) or Compound C (10 mM) in serum-free RPMI for 5 hours before exposure to 3% CSE for 24 hours. 
CSE preparation
10% CSE was prepared by bubbling smoke from one cigarette (Eighty-Eight Light containing 8.5 mg tar and 0.9 mg nicotine/cigarette) into 10 mL of serum-free culture medium at a rate of one cigarette per minute as described previously 29 . The CSE preparation was standardized by monitoring absorbance at 320 nm (optical density of 0.74±0.05) 30 . CSE solution filtered through an aseptic 0.22-mm filter was taken as 100%.
Transfection of AMPKa-1 siRNA
To knockdown AMPKa1 expression, human AMPKa1-specific small interfering RNA (siRNA) duplexes were obtained from Bioneer. A549 cells were transfected with human AMPK a1 siRNA duplexes (10 nM) using Lipofectamine RNAiMAX (Invitrogen) and experiments were performed 48 hours later. A non-silencing siRNA, which did not influence the expression of AMPK, was used as a negative control. After transfection, cells were treated with 3% CSE for 24 hours in serum-free medium.
Western blot analysis
Aliquots of cell lysates, tissue lysates, or membrane protein extracts were separated on 18% SDS-PAGE and blotted onto PVDF membranes (Amersham, Buckinghamshire, UK). The membranes were blocked with 5% skim milk in Tris-buffered 
Determination of IL-8 in culture medium
The concentrations of IL-8 in culture medium were measured with a human IL-8 enzyme-linked immunosorbent assay (ELISA) kit (R&D systems Inc., Minneapolis, MN, USA). Cell culture media were centrifuged at 14,000 ×g for 10 minutes at 4 o C, and supernatants stored at -80 o C prior to analysis.
Statistical analysis
Data are presented as means±SEM. For comparison between groups, the Mann-Whitney U test and Kruskal-Wallis tests were used. Statistical evaluations were undertaken with SPSS statistical package version 15.0 (SPSS Inc., Chicago, IL, USA). Statistical significance was defined at p<0.05.
Results
Cigarette smoking and poly(I:C) induce more extensive lung inflammation and emphysema in AMPKa1-deficient (AMPKa1-HT) mice
To elucidate the role of AMPKa1 in cigarette smokeinduced lung inflammation and emphysema, AMPKa1-deficient mice were exposed to cigarette smoke or challenged with poly(I:C). The AMPKa1-deficient (AMPKa1-HT) mice produced approximately 50% of the AMPKa of wild type mice ( Figure 1B ). Cigarette smoke exposure and poly(I:C) treatment induced significant increases in total BAL fluid cells, and neutrophil and macrophage counts, as well as in MLI, in both wild type and AMPKa1-HT mice. However total BAL fluid cells, lymphocyte and macrophage counts, and MLI were significantly higher in the AMPKa1-HT mice than the wild type mice after exposure to cigarette smoke or poly(I:C) ( Figure  2A-C) . 
CSE increases IL-8 production in A549 cells
Analysis of cell lysates showed that exposure of A549 cells to various concentrations (0%, 1.5%, 3%, and 4.5%) of CSE for 24 hours increased IL-8 protein in a concentration-dependent manner ( Figure 3A) . CSE exposure also increased the release of IL-8 from A549 cells ( Figure 3B ). We chose 3% CSE as the standard CSE concentration in subsequent experiments. Exposure of A549 cells to 3% CSE increased IL-8 protein levels and release of IL-8 in a time-dependent manner ( Figure 3C, D) .
CSE increases the phosphorylation of AMPK
Exposure of A549 cells to CSE increased the phosphorylation of AMPK within 60 minutes ( Figure 4A ). The adenosine analog AICAR, an AMPK activator, also increased the phosphorylation of AMPK, and Compound C, an AMPK inhibitor, inhibited it ( Figure 4B, C) . Pretreatment with a siRNA specific for AMPK reduced AMPK protein level ( Figure 4D ).
Activation of AMPK opposes the release of IL-8 by CSE
To determine whether AMPK is involved in the CSEinduced IL-8 production, A549 cells were pretreated with AICAR (1 mM) and Compound C (10 mM) for 5 hours, and then exposed to 3% CSE for 30 minutes. Cell lysates were subjected to immunoblot analysis and supernatant IL-8 was measured by ELISA. As shown in Figure 5A and C, AICAR decreased the CSE-induced IL-8 production and Compound C increased it. In addition, pretreatment with AMPK siRNA (10 nM) increased the CSE-induced IL-8 production, whereas sham pretreatment or negative (control) siRNA failed to have an effect (Figure 5B, D) .
Inhibition of AMPK activation with Compound C increases IL-1b-induced IL-8 secretion
IL-1b is an important pro-inflammatory cytokine participating in the pathogenesis of COPD. We tested whether AMPK activity also affected IL-1b-induced IL-8 production. IL-1b increased IL-8 secretion in A549 cells. AICAR pretreatment had no effect on secretion, whereas Compound C increased it ( Figure 6A, B) .
Discussion
To our knowledge, this is the first report that AMPK has an important role in reducing CSE-induced lung inflammation and emphysema. We observed increased cigarette smokeinduced lung inflammation and emphysema in AMPKa1-deficient mice, and in in vitro experiments we showed that inactivation of AMPK by Compound C or AMPK siRNA increased CSE-and IL-1b-induced IL-8 production in A549 cells.
A key mechanism in the pathogenesis of COPD is thought to be an abnormal inflammatory response in the lungs to the inhalation of toxic particles and gases derived from tobacco smoke 31 . The inflammatory response in COPD involves both innate and adaptive immune responses. Multiple inflammatory mediators are increased in COPD and are derived from inflammatory cells and structural cells of the airways and lungs 32 . Epithelial cells are provoked by cigarette smoke to produce inflammatory mediators, including TNF-a, IL-1b, IL-6, IL-8 (CXCL8) and granulocyte-macrophage colony-stimulating factor 33, 34 . We also showed that exposure of A549 cells to CSE increased the production of IL-8. A549 cells (adenocarcinomic human alveolar epithelial cells) are widely used as an in vitro model of type II pulmonary epithelial cells. A549 cells release neutrophil and monocytic chemotactic factors such as, IL-8, granulocyte colony-stimulating factor, leukotriene B4 and monocyte chemoattractant protein (MCP-1) in response to CSE 35 . IL-8 (CXCL8) is a potent neutrophil chemoattractant released by a variety of lung cells, including epithelial cells, macrophages, T cells and neutrophils themselves. It is a key chemokine in CSE-induced lung inflammation; its concentration is increased in the induced sputum of COPD patients and rises further during exacerbations 36, 37 . Although we demonstrated that inactivation of AMPK by Compound C or AMPK siRNA increased CSE and IL-1b-induced IL-8 production in A549 cells, the number of neutrophils in BAL fluid after exposure to cigarette smoke or poly(I:C) did not differ between AMPKa1-deficient and wild-type mice. In a recent study it was shown that activation of AMPK with metformin or berberine followed by stimulation with W-peptide, a mouse homolog of human IL-8, resulted in enhanced mouse neutrophil chemotaxis whereas stimulation with W-peptide led to a decrease in human neutrophil mobility. Thus our results may be explained by decreased neutrophil chemotaxis of AMPKa1-deficient mice 38 . Previous evidence suggests that AMPK affects inflammation both positively and negatively. In contrast to our findings, Tang et al. 15 reported that preventing AMPK activation with Compound C or AMPK siRNA reduced CSE-induced IL-8 production in human bronchial epithelial cells and lung inflammation in mice exposed to cigarette smoke for 1 month. However, several groups have reported that activation of AMPK by pharmacological activators inhibits inflammatory responses in human liver cells, bronchial epithelial cells, and murine macrophages and neutrophils [16] [17] [18] [19] . We also previously found that AICAR, an AMPK activator, attenuated poly(I:C)-and ovalbumin-induced airway inflammation and activation of nuclear factor kB (NF-kB), and the production of TNF-a in a murine model of asthma 20 . Furthermore, AMPKa1-deficient mice showed enhanced airway inflammation and fibrosis in response to challenges by both allergens and bleomycin, while metformin prevented airway inflammation and airway remodeling in a murine model of chronic asthma, at least in part by activating AMPK 21 . Thus, AMPK may promote or suppress inflammation induced by inflammatory stimuli depending on the cell type. AMPK activation may inhibit inflammation by multiple pathways, notably by inhibiting the NF-kB pathway. For example, AMPK activation in lipopolysaccharide-treated neutrophils was associated with decreased degradation of IkB and diminished nuclear translocation of NF-kB, as well as reduced release of TNF-a and IL-6 22 .
There is evidence that AMPK is an oxidative stress sensor and redox regulator in addition to its traditional role as an energy sensor and regulator. An imbalance between oxidants and antioxidants occurring in COPD results in oxidative stress, which underlies many of the pathogenic mechanisms in COPD. Several studies indicate that activation of AMPK inhibits oxidative stress 39, 40 . AMPK can be activated by increased intracellular reactive oxygen species (ROS) and reactive nitrogen species. Activated AMPK appears to be essential for maintaining intracellular redox status by inhibiting oxidant production by NADPH oxidases or by increasing the expression of antioxidant enzymes. Oxidative stress-induced activation of AMPK is believed to be important for the beneficial effects of many drugs. AMPK regulates the ROS/redox balance, autophagy, cell proliferation, cell apoptosis, cell polarity, mitochondrial function and genotoxic responses, either directly or indirectly, via numerous downstream pathways. Further investigations are required to clarify the exact molecular targets of AMPK under physiological and pathological conditions, and to develop potential strategies to modulate AMPK activation in COPD.
In conclusion, we demonstrate a novel role of AMPK in reducing lung inflammation and emphysema. AMPKa1-deficient mice have increased susceptibility to lung inflammation and emphysema in response to cigarette smoke. We also present evidence that AMPK reduces lung inflammation and emphysema by reducing IL-8 production. Further studies are required to expand our understanding of the role of AMPK in the pathogenesis of COPD, particularly with respect to limitation of CSE-induced lung inflammation.
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